Qsv Equity Investors LLC Catalyst Pharmaceuticals, Inc. Transaction History
Qsv Equity Investors LLC
- $95.8 Billion
- Q2 2024
A detailed history of Qsv Equity Investors LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Qsv Equity Investors LLC holds 84,137 shares of CPRX stock, worth $1.91 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
84,137Holding current value
$1.91 Million% of portfolio
1.36%Shares
1 transactions
Others Institutions Holding CPRX
# of Institutions
300Shares Held
97.4MCall Options Held
29.2KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$425 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$207 Million2.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.1MShares$184 Million0.0% of portfolio
-
State Street Corp Boston, MA6.03MShares$137 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$68.1 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.34B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...